Intervention of Bladder Cancer by CAR-T

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Bladder Cancer · Urothelial Carcinoma Bladder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Contact: Study coordinator (Lung-Ji Chang, PhD) · c@szgimi.org · 86-13671121909

Study leads

Lung-Ji Chang, PhD
Principal Investigator
Shenzhen Geno-Immune Medical Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Urothelial Carcinoma Bladder · Bladder Cancer

Abroad (travel likely)RecruitingPHASE1

Philadelphia, United States

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Solid Tumor, Adult · Bladder Cancer · Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1

North Melbourne, Australia

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

Urothelial Carcinoma Bladder

Abroad (travel likely)RecruitingPHASE2

Gainesville, United States

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Non-muscle-invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Mesa, United States · Tucson, United States